Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Micro-inflammation in Hemodialysis
NCT02929225Phase 1Completed
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Dec 2016
- Primary completion
- Jan 2018
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalis in chronic kidney disease (CKD) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Gut microbiota composition at 6 months. Started Dec 2016; status: completed.
02
Drugs
bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalis
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02929225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929225.